It has been used to treat cerebral edema in patients with glioblastoma since its introduction by Lyle French, MD, PhD, and Joseph Galicich, MD, in the early 1960s
Background: Corticosteroids are often used
We determined the efficacy of 10 mg of IV dexamethasone as adjuvant therapy for patients presenting to an emergency department (ED) with acute migraine
Fifty-four patients with acute cerebral infarction were included in a
The previously unrecognized bioavailability limitation of oral dexamethasone may explain individual instances of apparent steroid-resistant neurological disease, and suggests the
The RECOVERY trial provides evidence that treatment with dexamethasone at a dose of 6 mg once daily for up to 10 days reduces 28-day mortality in patients with
The two classes of drugs most often cited as causing hiccups are corticosteroids and benzodiazepines
Learn More
American Academy of Neurology: Dexamethasone, intravenous: Used to prevent recurrence: Dihydroergotamine, parenteral (DHE 45) Severe nausea is common; do not use within 24 hours of
Objective: To validate the use of administrative data to identify patients with bacterial meningitis and quantify the rate of dexamethasone administration as defined in the American Academy of Neurology Inpatient and Emergency Care Quality Measurement Set
Jennifer Robblee, a neurologist and an assistant professor in the Department of Neurology at Barrow Neurological Institute in Phoenix, Arizona
27 (2) 202
8) and decreased significantly (p < 0
I have been on Dexamethasone from the onset of my condition (up and down on doses The combination of a 5-HT 3 receptor antagonist, aprepitant, and dexamethasone has been recommended for prophylaxis in patients treated with moderately or highly emetogenic chemotherapy and are therefore at high risk for developing CINV
8) and decreased significantly (p less than 0
Data sources Electronic databases (Cochrane Central Register of Controlled Trials, Medline, Embase, LILACS, and CINAHL), conference proceedings, clinical
Less is known about psychiatric or side effects on central nervous system, as catatonia, decreased concentration, agitation, insomnia, and A total of 190 of 252 patients (75
The RECOVERY trial provides evidence that treatment with dexamethasone at a dose of 6 mg once daily for up to 10 days reduces 28-day mortality in patients with Covid-19 who are receiving Treatment with dexamethasone is recommended for symptom relief in adult patients with primary high-grade glioma and cerebral edema